AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33503074 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age at ART initiation (age 5–9 years)
Number of subjects: 300
Study 33503074 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age at ART initiation (age 10–14 years)
Number of subjects: 300
Study 34210290 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue anti-PD-1 treatment until disease progression/unacceptable toxicity/for at least 2 years in the absence of disease progression/unacceptable toxicity
Number of subjects: 1208
Study 34210290 — intervention group
Group type: COMPARATOR
Intervention: Stop treatment
Number of subjects: 1208
Study 34210290 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue anti-PD-1 treatment
Number of subjects: 1208
Study 32969024 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) for patients arriving between 6 and 24 hours with ASPECTS ≥7
Number of subjects: 56
Study 32969024 — intervention group
Group type: COMPARATOR
Intervention: Endovascular treatment (EVT) for patients arriving between 0 and 6 hours
Number of subjects: 56
Study 33028352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent calorie restriction (ICR) - a very low‐calorie diet during 3 days of the week for 8 weeks
Number of subjects: 88
Study 33028352 — intervention group
Group type: COMPARATOR
Intervention: Continuous calorie restriction (CCR) - for 8 weeks
Number of subjects: 88
Study 35294623 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 21300
Study 35294623 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonists (VKAs)
Number of subjects: 21300
Study 33612706 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined hs-CRP using IVCRP
Number of subjects: 10521
Study 33612706 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined hs-CRP using IVAsian
Number of subjects: 10521
Study 33612706 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-Egger method for IVCRP
Number of subjects: 10521
Study 33612706 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-Egger method for IVAsian
Number of subjects: 10521
Study 33095798 — intervention group
Group type: EXPERIMENTAL
Intervention: E-Cigarette (EC) arm; received an EC starter kit and 4-weeks supply of e-liquid
Number of subjects: 80
Study 33095798 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) arm; received advice to quit and signposting to the local Stop Smoking Service
Number of subjects: 80
Study 33095798 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EC and UC arms
Number of subjects: 80
Study 33095798 — intervention group
Group type: EXPERIMENTAL
Intervention: E-Cigarette (EC) arm
Number of subjects: 80
Study 35984327 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA) measured through Global Physical Activity Questionnaire (GPAQ) and wearable activity data.
Number of subjects: 66
Study 35984327 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA) measured through Previous Day Physical Activity Recalls (PDPAR).
Number of subjects: 66
Study 34438103 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal corticosteroids (INCS)
Number of subjects: 72147
Study 35403447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib 60 mg/day tablet
Number of subjects: 247
Study 35403447 — intervention group
Group type: COMPARATOR
Intervention: Cabozantinib 140 mg/day capsules
Number of subjects: 247
Study 33009719 — intervention group
Group type: EXPERIMENTAL
Intervention: EyeSi Surgical Simulator proficiency test
Number of subjects: 23
Study 32764830 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmitters sharing their feelings with receivers
Number of subjects: 158
Study 32764830 — intervention group
Group type: EXPERIMENTAL
Intervention: Receivers communicating with other group members
Number of subjects: 158
Study 34289471 — intervention group
Group type: EXPERIMENTAL
Intervention: High UFNET rate (>1.75 mL/kg/h)
Number of subjects: 1433
Study 34289471 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle UFNET rate (1.01‐1.75 mL/kg/h)
Number of subjects: 1433
Study 34289471 — intervention group
Group type: EXPERIMENTAL
Intervention: Low UFNET rate (<1.01 mL/kg/h)
Number of subjects: 1433
Study 34289471 — intervention group
Group type: COMPARATOR
Intervention: Higher UFNET rate tertile compared with middle tertile
Number of subjects: 1433
Study 34289471 — intervention group
Group type: COMPARATOR
Intervention: Higher UFNET rate tertile compared with lower tertile
Number of subjects: 1433
Study 34289471 — intervention group
Group type: EXPERIMENTAL
Intervention: Every 1.0 mL/kg/h increase in UFNET rate
Number of subjects: 1433
Study 34289471 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal increases in UFNET rates
Number of subjects: 1433
Study 34289471 — intervention group
Group type: EXPERIMENTAL
Intervention: UFNET rates >1.75 mL/kg/h compared with rates 1.01‐1.75 and <1.01 mL/kg/h
Number of subjects: 1433
Study 33075715 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification methods for diagnostic support through peripheral blood smear images of red blood cells.
Number of subjects: 0
Study 33075715 — intervention group
Group type: EXPERIMENTAL
Intervention: Feature extraction methods and machine learning methods for classifying morphology.
Number of subjects: 0
Study 33075715 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized and Grid search for parameter optimization.
Number of subjects: 0
Study 33075715 — intervention group
Group type: EXPERIMENTAL
Intervention: Selection of important features for classification.
Number of subjects: 0
Study 33956409 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopy group (FG)
Number of subjects: 120
Study 33956409 — intervention group
Group type: COMPARATOR
Intervention: Nonfluoroscopy group (NFG)
Number of subjects: 120
Study 32326304 — intervention group
Group type: EXPERIMENTAL
Intervention: Get Ready intervention (GR)
Number of subjects: 31
Study 32326304 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 31
Study 35069783 — intervention group
Group type: EXPERIMENTAL
Intervention: 64-slice spiral CT images based on the DLEM algorithm
Number of subjects: 120
Study 35069783 — intervention group
Group type: COMPARATOR
Intervention: Conventional 64-slice spiral CT images
Number of subjects: 120
Study 35069783 — intervention group
Group type: EXPERIMENTAL
Intervention: 64-slice spiral CT images based on the DLEM algorithm (after processing)
Number of subjects: 120
Study 35069783 — intervention group
Group type: EXPERIMENTAL
Intervention: 64-slice spiral CT images based on the DLEM algorithm (before processing)
Number of subjects: 120
Study 32969962 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label positive suggestions
Number of subjects: 112
Study 32969962 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-label positive suggestions
Number of subjects: 112
Study 32969962 — intervention group
Group type: COMPARATOR
Intervention: Open-label negative suggestions
Number of subjects: 112
Study 32969962 — intervention group
Group type: COMPARATOR
Intervention: Closed-label negative suggestions
Number of subjects: 112
Study 32868938 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking
Number of subjects: 39
Study 32868938 — intervention group
Group type: COMPARATOR
Intervention: Standard general exercise programme
Number of subjects: 39
Study 36214664 — intervention group
Group type: EXPERIMENTAL
Intervention: In-vehicle spatial-simultaneous distractions
Number of subjects: 27
Study 36214664 — intervention group
Group type: COMPARATOR
Intervention: In-vehicle spatial-sequential distractions
Number of subjects: 27
Study 34492291 — intervention group
Group type: EXPERIMENTAL
Intervention: pMDI+VMN+Combihaler
Number of subjects: 24
Study 34492291 — intervention group
Group type: EXPERIMENTAL
Intervention: VMN
Number of subjects: 24
Study 34492291 — intervention group
Group type: COMPARATOR
Intervention: pMDI+T‐piece
Number of subjects: 24
Study 35939578 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg litifilimab
Number of subjects: 132
Study 35939578 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg litifilimab
Number of subjects: 132
Study 35939578 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 mg litifilimab
Number of subjects: 132
Study 35939578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 33607609 — intervention group
Group type: EXPERIMENTAL
Intervention: Nominal group technique sessions
Number of subjects: 79
Study 35144164 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-recorded lecture
Number of subjects: 160
Study 35144164 — intervention group
Group type: COMPARATOR
Intervention: Live lecture
Number of subjects: 160
Study 33705665 — intervention group
Group type: EXPERIMENTAL
Intervention: MV130
Number of subjects: 120
Study 33705665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 32279106 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic transtympanic myringoplasty (ETM)
Number of subjects: 40
Study 32279106 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic type I tympanoplasty (ETT)
Number of subjects: 40
Study 35354635 — intervention group
Group type: EXPERIMENTAL
Intervention: GelStix nucleus augmentation device
Number of subjects: 72
Study 35354635 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 72
Study 35747962 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus 80 mg/day nano-curcumin capsules
Number of subjects: 42
Study 35747962 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy plus placebo
Number of subjects: 42
Study 32912725 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg of aspirin
Number of subjects: 107
Study 32912725 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg of aspirin
Number of subjects: 107
Study 36195055 — intervention group
Group type: EXPERIMENTAL
Intervention: Online CRC risk calculator with risk-based recommendations
Number of subjects: 1495
Study 36195055 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (UCG)
Number of subjects: 1495
Study 36162889 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture on PC6 and CV24 acupuncture points (0.8 J, 4 seconds, energy density 2.854 J/cm2)
Number of subjects: 30
Study 36162889 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture on PC6 and CV24 acupuncture points
Number of subjects: 30
Study 36162889 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham treatment)
Number of subjects: 30
Study 32087357 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial-eluting envelope (TYRX Absorbable Antibacterial Envelope)
Number of subjects: 6800
Study 32087357 — intervention group
Group type: COMPARATOR
Intervention: Control group (no envelope)
Number of subjects: 6800
Study 35481691 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular transcutaneous vagal nerve stimulation (10 minutes each side)
Number of subjects: 16
Study 35481691 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (10 minutes each side)
Number of subjects: 16
Study 33906292 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical expression of RET in cancer samples
Number of subjects: 60
Study 33906292 — intervention group
Group type: COMPARATOR
Intervention: Normal control (adjacent tumor-free section)
Number of subjects: 60
Study 35231057 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassionate Mind Training program for Teachers (CMT‐T)
Number of subjects: 155
Study 35231057 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (WLC)
Number of subjects: 155
Study 35231057 — intervention group
Group type: EXPERIMENTAL
Intervention: CMT‐T
Number of subjects: 155
Study 34858175 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Ginseng (RG) - 3 g/d for 12 weeks
Number of subjects: 52
Study 34858175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 35833523 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle interventions
Number of subjects: 0
Study 35833523 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 35833523 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term interventions to prevent diabetes
Number of subjects: 0
Study 35833523 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic interventions at the time of prediabetes
Number of subjects: 0
Study 35833523 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediabetes
Number of subjects: 0
Study 34487647 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin plus Levamisole
Number of subjects: 118
Study 34487647 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin alone
Number of subjects: 118
Study 32028085 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused ultrasound (FUS) treatment
Number of subjects: 0
Study 35168840 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to get vaccinated
Number of subjects: 172
Study 35168840 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerns about COVID-19 vaccine development and mistrust in vaccines
Number of subjects: 172
Study 35168840 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of employment due to COVID-19
Number of subjects: 172
Study 35168840 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of household income due to COVID-19
Number of subjects: 172
Study 35168840 — intervention group
Group type: EXPERIMENTAL
Intervention: Inability to pay bills and buy food due to COVID-19
Number of subjects: 172
Study 34772437 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive strategy (CARS)
Number of subjects: 0
Study 34772437 — intervention group
Group type: COMPARATOR
Intervention: Conventional strategy (FDI)
Number of subjects: 0
Study 32779057 — intervention group
Group type: EXPERIMENTAL
Intervention: SZC 5 g
Number of subjects: 103
Study 32779057 — intervention group
Group type: EXPERIMENTAL
Intervention: SZC 10 g
Number of subjects: 103
Study 32779057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 35378692 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent sequence of objects and locations
Number of subjects: 0
Study 35378692 — intervention group
Group type: COMPARATOR
Intervention: Randomized sequence of objects and locations
Number of subjects: 0
Study 33538655 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6
Number of subjects: 680
Study 33538655 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-8
Number of subjects: 680
Study 33538655 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 680
Study 33538655 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 and CRP
Number of subjects: 680
Study 33538655 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1β
Number of subjects: 680
Study 32222367 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP-I/DEX
Number of subjects: 753
Study 32222367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 753
Study 32222367 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP-I
Number of subjects: 753
Study 35286606 — intervention group
Group type: EXPERIMENTAL
Intervention: E. faecalis lotion
Number of subjects: 20
Study 35286606 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lotion (control)
Number of subjects: 20
Study 32439823 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin treatment
Number of subjects: 2
Study 32439823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 35641125 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg/day
Number of subjects: 451
Study 35641125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451
Study 32524293 — intervention group
Group type: EXPERIMENTAL
Intervention: RDI < 70%
Number of subjects: 211
Study 32524293 — intervention group
Group type: EXPERIMENTAL
Intervention: CCI ≥ 2
Number of subjects: 211
Study 32524293 — intervention group
Group type: EXPERIMENTAL
Intervention: CCI < 2 and RDI ≥ 70%
Number of subjects: 211
Study 32524293 — intervention group
Group type: EXPERIMENTAL
Intervention: CCI ≥ 2 and RDI < 70%
Number of subjects: 211
Study 32524293 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly DLBCL patients (65 years <) with RDI < 70%
Number of subjects: 211
Study 33084095 — intervention group
Group type: EXPERIMENTAL
Intervention: Charcot foot group
Number of subjects: 20
Study 33084095 — intervention group
Group type: COMPARATOR
Intervention: non‐Charcot foot group
Number of subjects: 20
Study 32487088 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to health care access for individuals with disabilities
Number of subjects: 12
Study 32487088 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudinal factors
Number of subjects: 12
Study 36164769 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural language processing (NLP) methods using bidirectional encoder representations from transformers
Number of subjects: 39
Study 36164769 — intervention group
Group type: COMPARATOR
Intervention: Clinical raters
Number of subjects: 39
Study 34448273 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC monotherapy (Tacrolimus only after tapering Mycophenolate mofetil)
Number of subjects: 0
Study 34448273 — intervention group
Group type: COMPARATOR
Intervention: Dual therapy (Tacrolimus and Mycophenolate mofetil)
Number of subjects: 0
Study 32447575 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel strength training (NST) involving eccentric overloaded strength training and neuromuscular electrical stimulation (NMES)
Number of subjects: 22
Study 32447575 — intervention group
Group type: COMPARATOR
Intervention: Conventional strength training (CST) involving dynamic resistance exercises matched for training volume
Number of subjects: 22
Study 35700440 — intervention group
Group type: EXPERIMENTAL
Intervention: Burosumab
Number of subjects: 4
Study 35700440 — intervention group
Group type: COMPARATOR
Intervention: Orthopedic surgery
Number of subjects: 4
Study 33603019 — intervention group
Group type: EXPERIMENTAL
Intervention: K‐prototypes clustering method
Number of subjects: 0
Study 33603019 — intervention group
Group type: EXPERIMENTAL
Intervention: Kamila algorithm
Number of subjects: 0
Study 33603019 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent Class Model (LCM)
Number of subjects: 0
Study 33603019 — intervention group
Group type: COMPARATOR
Intervention: Partitioning Around Medoids
Number of subjects: 0
Study 33603019 — intervention group
Group type: COMPARATOR
Intervention: Hierarchical Clustering
Number of subjects: 0
Study 33603019 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent Class Analysis
Number of subjects: 0
Study 33603019 — intervention group
Group type: COMPARATOR
Intervention: Gower distance
Number of subjects: 0
Study 33603019 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised Extra Trees dissimilarity
Number of subjects: 0
Study 32148225 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) with helmet
Number of subjects: 26
Study 35102797 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 0
Study 35102797 — intervention group
Group type: COMPARATOR
Intervention: Best medical management (BMM)
Number of subjects: 0
Study 32398633 — intervention group
Group type: COMPARATOR
Intervention: C90 (80% of 1 repetition maximum, mean velocity dropped to 90%)
Number of subjects: 11
Study 32398633 — intervention group
Group type: COMPARATOR
Intervention: C70 (80% of 1 repetition maximum, mean velocity dropped to 70%)
Number of subjects: 11
Study 32398633 — intervention group
Group type: COMPARATOR
Intervention: Control (no bench press performed)
Number of subjects: 11
Study 35255530 — intervention group
Group type: COMPARATOR
Intervention: Esketamine 0 mg/kg
Number of subjects: 92
Study 35255530 — intervention group
Group type: COMPARATOR
Intervention: Esketamine 0.25 mg/kg
Number of subjects: 92
Study 35255530 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 0.5 mg/kg
Number of subjects: 92
Study 35255530 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 1 mg/kg
Number of subjects: 92
Study 32940090 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 0
Study 32940090 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine
Number of subjects: 0
Study 32940090 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculosis vaccine
Number of subjects: 0
Study 32940090 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 vaccines (various candidates)
Number of subjects: 0
Study 35130354 — intervention group
Group type: EXPERIMENTAL
Intervention: Managing Emotions Group (MEG) - an eight-session DBT-informed skills group
Number of subjects: 48
Study 33706066 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai Yoga (TY)
Number of subjects: 22
Study 33706066 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 22
Study 35381912 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension music
Number of subjects: 50
Study 35381912 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral music
Number of subjects: 50
Study 35381912 — intervention group
Group type: COMPARATOR
Intervention: Silence
Number of subjects: 50
Study 35381912 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension perception
Number of subjects: 50
Study 35381912 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower musical tension perception
Number of subjects: 50
Study 33466233 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (Cr) 20 g/day for 1 week (loading phase) followed by 5 g/day for 7 weeks (maintenance phase)
Number of subjects: 29
Study 33466233 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 29
Study 33466233 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (Cr)
Number of subjects: 29
Study 32669145 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine and paliperidone palmitate combination therapy
Number of subjects: 50
Study 35483678 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine nebulization 1 mcg/kg in 3 mL of 0.9% saline
Number of subjects: 90
Study 35483678 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine 1 mcg/kg in 10 mL of 0.9% saline
Number of subjects: 90
Study 35483678 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl 2 mcg/kg in 10 mL of 0.9% saline
Number of subjects: 90
Study 34562209 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided subcostal anterior quadratus lumborum block (QLB)
Number of subjects: 60